Earth Science Tech, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Earth Science Tech, Inc. (ETST) is a holding company focused on the health and wellness industry through compounding pharmaceuticals, telemedicine services, and real estate development; it operates subsidiaries including RxCompoundStore.com, LLC for pharmacy compounding; Peaks Curative, LLC, a telemedicine referral platform offering asynchronous consultations for compounded medications in areas such as sexual health and physical performance; Mister Meds, LLC, a compounding pharmacy in Abilene, Texas with sterile and hazardous drug capabilities; Avenvi, LLC for real estate; Las Villas Health Care, Inc. and DOConsultations, LLC for wellness clinics and online telemedicine; an 80% interest in MagneChef for related health services; and expansions into veterinary telemedicine via Zoolzy.com. The company, founded in 2010 and headquartered in Miami, Florida, primarily serves patients seeking personalized medications and consultations across the United States, with ongoing pharmacy licensure expansions to additional states. Recent developments include the October 2024 acquisition of Mister Meds, which gained full compounding licensure in March 2025; April 2025 acquisitions of Las Villas Health Care, Inc. and DOConsultations.com, LLC for $200,000 to bolster wellness and telemedicine; the veterinary market entry through Zoolzy.com; an August 2025 increase in its share repurchase program to $10 million; and a board-approved reduction of authorized common shares from 350 million to 300 million.
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026
Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
Earth Science Tech (OTCMKTS:ETST) vs. Pharming Group (NASDAQ:PHAR) Head-To-Head Survey
Earth Science Tech, Inc. (ETST) Launches MyOnlineConsultation.com, Finalizing a Fully Vertically Integrated Telehealth and Pharmacy Ecosystem
Earth Science Tech, Inc. Announces Initiatives to Advance Public Company Strategy; Expects Approximately $1.4 Million in Annualized Savings and Fiscal 2026 Net Income Growth of More Than 40%, from $3.3 Million to $4.7 Million
Earth Science Tech, Inc. (ETST) Upgrades Audit Capabilities, Engages Semple, Marchal & Cooper, LLP as Independent PCAOB Auditor to Support Continued Expansion
Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026
IBN Initiates Coverage of Earth Science Tech Inc.
Earth Science Tech, Inc. (ETST) Issues Directive Industry Classification Update to SIC 2834; Formally Identifies as Pharmaceutical Entity Since 2022
Earth Science Tech, Inc. Receives FINRA Clearance on Form 211 to Initiate Quotations
Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results
Earth Science Tech, Inc. Boosts Share Repurchase Program to $10 Million and Extends Authorization Through 2027
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier
Earth Science Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million
The Zacks Analyst Blog Tesla, UnitedHealth Group, Oracle and Earth Science Tech
Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit